Target strikes deal with jeweler Kendra Scott as it gets ready for holiday season

Target strikes deal with jeweler Kendra Scott as it gets ready for holiday season


Shoppers will soon see jewelry designed by Kendra Scott at about 150 Target stores. Most of the items will be under $40.

Target

Target said Tuesday that it has struck a deal with jeweler Kendra Scott to carry exclusive collections of earrings, bracelets and more, as it looks to get its sparkle back ahead of the key holiday season.

The cheap chic retailer has established a reputation for launching its own brands and dedicating parts of its stores to merchandise from well-recognized national names, such as Levi Strauss, Disney and Apple. It has mini Ulta Beauty shops inside of a growing number of its stores, too.

With the new deal, colorful jewelry designed by Kendra Scott for Target will be available online and at about 150 stores. The first collection of more than 200 items, which range from $15 to $60, will hit on October 22 — just as customers are putting holiday shopping lists together and snagging early gifts. Most items cost less than $40, Target said.

The big-box retailer declined to share the deal’s financial terms, but described it as “a long-term strategic partnership.”

The first Kendra Scott collection will hit Target’s shelves in late October.

Target

The past year and a half has brought a sharp dose of reality for Target, which thrived and gained market share during the pandemic. The retailer dealt with the fallout of having the wrong merchandise last year as shoppers went out and about again.

In more recent quarters, Target shoppers have pulled back on buying clothing, home decor and other discretionary items while they spend more on experiences and pay higher grocery bills because of inflation. The company also faced public backlash over its Pride merchandise collection, which dinged sales in the most recent quarter. It has also pointed to organized retail theft as a challenge weighing on profits.

Target cut its forecast in August. It said it now expects comparable sales to drop by around mid single digits, and earnings per share to range from $7 to $8 for the full fiscal year.

Shares of Target have fallen nearly 18% this year, far behind the 17% gains of the S&P 500. The company’s stock hit a 52-week low in late August.

On an call with reporters last month, CEO Brian Cornell said Target expects consumers will feel pressured in the coming months because of the return of student loan payments, rising interest rates, and the still higher cost of necessities.

Yet Target has had luck getting shoppers to add some discretionary items to their baskets: makeup and other beauty items.

Sales at its mini Ulta shops in the fiscal second quarter more than doubled, and sales of other beauty items posted double-digit gains compared with a year ago, Target’s Chief Growth Officer Christina Hennington said last month.

That’s a formula it wants to replicate in other categories like jewelry.



Source

Pricey NFL, NBA ownership stakes are pushing investors to smaller leagues and driving valuations higher
Business

Pricey NFL, NBA ownership stakes are pushing investors to smaller leagues and driving valuations higher

Trinity Rodman #2 of Washington Spirit evades Sarah Schupansky #11 of Gotham FC during the NWSL Championship 2025 final between Washington Spirit and NJ/NY Gotham FC at PayPal Park on November 22, 2025 in San Jose, California. Lyndsay Radnedge/isi Photos | Isi Photos | Getty Images A version of this article first appeared in the […]

Read More
Hershey says GLP-1s are driving higher gum and mint sales
Business

Hershey says GLP-1s are driving higher gum and mint sales

Packages of Ice Breakers spearmint mints Mints are displayed at a Costco Wholesale store on April 27, 2025 in San Diego, California. Kevin Carter | Getty Images Hershey is seeing higher sales for its mints and gum — thanks to the growing use of GLP-1 drugs. “We’ve also seen strong demand for gum and mints, […]

Read More
More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says
Business

More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says

More than 20,000 people have started taking Eli Lilly‘s GLP-1 pill Foundayo in its first few weeks on the market, Lilly CEO Dave Ricks told CNBC on Thursday. The FDA approved Lilly’s once-daily pill Foundayo earlier this month, making it the second oral GLP-1 drug behind Novo Nordisk’s Wegovy pill. Investors have been closely tracking […]

Read More